Raising Awareness and Funds to Support Research and Programs at the Kellogg Eye Center

MHBB 2015: MARCH 19 & 20, 2015


Make A Donation


Event Description

History of the Event

This Year's Research Program



Contact Information


This Year's Donations

MHBB 2014 donations will be dedicated to support the research into diagnosing and treating retinal dystrophies at the Kellogg Eye Center!

Every year, the proceeds from March Hoops To BEAT Blindness are dedicated to a specific research program at the Kellogg Eye Center . The program is chosen for its innovative approach and focus on treating and finding cures to blinding conditions.

I am happy to announce all donations from  March Hoops to BEAT Blindness 2014  will go to support a program to diagnose patients with retinal dystrophies. It will help patients AROUND THE WORLD !!!!

Dr. K. Thiran Jayasundera, M.D., FACS, FRSC, FRANZCO and his team are working to create an automated diagnostic tool for diagnosing retinal dystrophies. We use image processing and algorithms to identify features of different diseases, so that a doctor anywhere in the world could access the information and compare their patient to the database, and we would provide the most likely diagnosis and causative gene. This would help the doctor to confirm the diagnosis, order appropriate genetic testing, and determine if any treatments or clinical trials are available for the patient's vision-threatening condition.

What is Retinal Dystrophy?
Retinal Dystrophies are a group of inherited or genetic conditions which cause worsening vision. They are conditions which cause blindness by affecting the retina - the light-sensitive cells in the back of the eye.

How Will This BEAT Blindness? 
There are many different retinal dystrophies, each with different causes and treatment options. The effectiveness of the treatment options vary from one individual patient to the next, and can be dependent on the specific type of genetic mutation.

With recent advances in genetic testing, and innovative treatments being developed every day, now is the time useful information about each patient can be captured and shared. Developing a "snapshot" profile of the patient - including genetic information, family history, images, and other information - matches can be found with other patients with similar conditions. This helps identify the specific gene mutation causing the disease as well as find treatment options and possible outcomes.

The patients with these conditions, and their doctors, can consider the treatments pursued in similar cases with patients around the world. They can determine the best course of treatment for the individual patient.

The "Bionic Eye"

Dr. Jayasundera is also working on the Argus II device, which is an artificial retina also referred to as the "bionic eye". It is a device which could provide partial sight for patients with late-stage retinitis pigmentosa (a specific group of diseases which cause a slow but Retinal prosthesis implantprogressive loss of vision due to the loss of retinal cells).

The device was developed by Second Sight Medical Products, Inc. and was approved by the Food and Drug Administration in February 2013. It is now offered at the University of Michigan Kellogg Eye Center , one of 12 major centers across the country to offer the implant.

This system uses a retinal prosthesis and special eye glasses. The retinal prosthesis is implanted in the eye and the patient wears glasses equipped with a special camera which transmits wirelessly to the prosthesis. The prosthesis sends the signals of the images frGlasses, a video processing unit (VPU) and a cable are part of the Argus II Systemom the camera to the brain.

To learn more about the device and the latest developments, click here, or visit the University of Michigan Kellogg Eye Center website (www.kellogg.umich.edu).



How Will This Help Patients? 
Patients receiving a prognosis of a retinal dystrophy disease face difficult and heartbreaking decisions. Just knowing that there are other people with the same conditions, and the treatments they pursued, can be a big help. Considering treatment options is never easy and outcomes are very uncertain. Having access to the experience of other patients helps patients cope with the difficulties and challenges they face.



To learn more about this and related research programs Click Here . For the Retina Services at the Kellogg Eye Center call 734-763-5874.